CH650680A5 - Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. - Google Patents
Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. Download PDFInfo
- Publication number
- CH650680A5 CH650680A5 CH5011/82A CH501182A CH650680A5 CH 650680 A5 CH650680 A5 CH 650680A5 CH 5011/82 A CH5011/82 A CH 5011/82A CH 501182 A CH501182 A CH 501182A CH 650680 A5 CH650680 A5 CH 650680A5
- Authority
- CH
- Switzerland
- Prior art keywords
- human
- insulin
- proinsulin
- peptide
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29671681A | 1981-08-27 | 1981-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH650680A5 true CH650680A5 (de) | 1985-08-15 |
Family
ID=23143244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5011/82A CH650680A5 (de) | 1981-08-27 | 1982-08-23 | Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5846026A (xx) |
| AU (1) | AU551734B2 (xx) |
| BE (1) | BE894187A (xx) |
| CA (1) | CA1176159A (xx) |
| CH (1) | CH650680A5 (xx) |
| DE (1) | DE3232035A1 (xx) |
| FR (1) | FR2511868B1 (xx) |
| GB (1) | GB2104381B (xx) |
| IL (1) | IL66612A (xx) |
| IT (1) | IT1153183B (xx) |
| LU (1) | LU84357A1 (xx) |
| MW (1) | MW3982A1 (xx) |
| NL (1) | NL8203313A (xx) |
| NZ (1) | NZ201685A (xx) |
| PH (1) | PH18640A (xx) |
| SE (1) | SE8204872L (xx) |
| ZA (1) | ZA826160B (xx) |
| ZW (1) | ZW17682A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652548A (en) * | 1981-08-27 | 1987-03-24 | Eli Lilly And Company | Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin |
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| JPS62222379A (ja) * | 1986-03-25 | 1987-09-30 | Mutoh Ind Ltd | コンピュータグラフィックスにおける隠線・隠面処理方法 |
| US9389582B2 (en) | 2014-06-02 | 2016-07-12 | Lexmark International, Inc. | Replaceable unit for an image forming device having magnets of varying angular offset for toner level sensing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789080A (en) * | 1952-08-14 | 1957-04-16 | Christensen Henry Marinus | Insulin-albumin compositions |
| CH330318A (de) * | 1953-09-08 | 1958-05-31 | British Drug Houses Ltd | Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit |
-
1982
- 1982-08-23 CA CA000409911A patent/CA1176159A/en not_active Expired
- 1982-08-23 IL IL66612A patent/IL66612A/xx unknown
- 1982-08-23 CH CH5011/82A patent/CH650680A5/de not_active IP Right Cessation
- 1982-08-23 ZW ZW176/82A patent/ZW17682A1/xx unknown
- 1982-08-24 ZA ZA826160A patent/ZA826160B/xx unknown
- 1982-08-24 NL NL8203313A patent/NL8203313A/nl not_active Application Discontinuation
- 1982-08-24 NZ NZ201685A patent/NZ201685A/xx unknown
- 1982-08-24 MW MW39/82A patent/MW3982A1/xx unknown
- 1982-08-24 PH PH27769A patent/PH18640A/en unknown
- 1982-08-24 BE BE6/47703A patent/BE894187A/fr not_active IP Right Cessation
- 1982-08-25 FR FR8214596A patent/FR2511868B1/fr not_active Expired
- 1982-08-25 JP JP57148496A patent/JPS5846026A/ja active Pending
- 1982-08-25 SE SE8204872A patent/SE8204872L/ not_active Application Discontinuation
- 1982-08-25 AU AU87597/82A patent/AU551734B2/en not_active Ceased
- 1982-08-26 GB GB08224483A patent/GB2104381B/en not_active Expired
- 1982-08-26 LU LU84357A patent/LU84357A1/fr unknown
- 1982-08-27 IT IT23018/82A patent/IT1153183B/it active
- 1982-08-27 DE DE19823232035 patent/DE3232035A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ZW17682A1 (en) | 1982-11-24 |
| LU84357A1 (fr) | 1983-02-28 |
| AU8759782A (en) | 1983-03-03 |
| FR2511868A1 (fr) | 1983-03-04 |
| ZA826160B (en) | 1984-04-25 |
| IL66612A (en) | 1985-11-29 |
| SE8204872D0 (sv) | 1982-08-25 |
| IT1153183B (it) | 1987-01-14 |
| PH18640A (en) | 1985-08-23 |
| CA1176159A (en) | 1984-10-16 |
| GB2104381B (en) | 1984-12-05 |
| NL8203313A (nl) | 1983-03-16 |
| GB2104381A (en) | 1983-03-09 |
| SE8204872L (sv) | 1983-02-28 |
| BE894187A (fr) | 1983-02-24 |
| AU551734B2 (en) | 1986-05-08 |
| JPS5846026A (ja) | 1983-03-17 |
| DE3232035A1 (de) | 1983-03-10 |
| MW3982A1 (en) | 1984-06-13 |
| IT8223018A0 (it) | 1982-08-27 |
| FR2511868B1 (fr) | 1986-05-09 |
| NZ201685A (en) | 1985-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT408611B (de) | Insulinanalogon-protamin-komplex | |
| DE19726167B4 (de) | Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung | |
| EP2451437B1 (de) | Wässrige insulinzubereitungen enthaltend methionin | |
| DE69019534T2 (de) | Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. | |
| AT408720B (de) | Parenterale pharmazeutische formulierung eines humaninsulinanalogon-komplexes | |
| DE69428860T2 (de) | Insulin Formulierung | |
| EP0357978B1 (de) | Pharmazeutische Zubereitung zur Behandlung des Diabetes mellitus | |
| EP2289539B1 (de) | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität | |
| DE69434963T2 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
| DE69816409T2 (de) | Kristallines Parathyroidhormon | |
| DE69807679T2 (de) | Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren | |
| DE69708121T2 (de) | Halogenid-enthaltende insulinzubereitungen | |
| DE69027217T2 (de) | Behandlung von insulinresistentem diabetes | |
| WO2011003823A1 (de) | Langsamwirkende insulinzubereitungen | |
| DE60005806T2 (de) | Zusammensetzung auf basis gegensätzlich geladener polypeptide | |
| CH650678A5 (de) | Pharmazeutisches mittel aus human-insulin und human-proinsulin. | |
| DE3232034C2 (xx) | ||
| EP1084248B1 (de) | Neue insulinanaloga mit erhöhter zinkbindung | |
| DE69417397T2 (de) | Lösung, die igf-1 enthält | |
| CH650677A5 (de) | Gegen diabetes mellitus wirksames pharmazeutisches mittel. | |
| CH650680A5 (de) | Pharmazeutisches mittel aus human-insulin, human-c-peptid und human-proinsulin. | |
| DE69231263T2 (de) | Calcitonin enthaltende pharmazeutische Zusammensetzungen | |
| DE69710918T2 (de) | Topisches präparat zur abgabe eines peptidarzneimittels in lebewesen | |
| EP0001124A1 (de) | Neue Arzneimittelmischungen zur Verbesserung der Glucoseverwertung in den Zellen und Senkung des Blutzuckerspiegels | |
| EP1558641B1 (de) | Kristalle von insulinanaloga und verfahren zu ihrer herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |